ReviewBiomedicines2025
Point-of-Care Transesophageal Echocardiography in Emergency and Intensive Care: An Evolving Imaging Modality.
Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A closed-loop myocardial infarction theranostic platform activated by macrophage-derived nitric oxide and acidic microenvironment.Bioactive materials · 2026Article
- The Right Ventricle in Cardiac Critical Care: Pathophysiology, Evaluation and Management.Medicina (Kaunas, Lithuania) · 2026Review
- Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions.Life (Basel, Switzerland) · 2026Review
- Extracorporeal Life Support in Severe Accidental Hypothermia: Mechanisms, Challenges and Clinical Horizons.Journal of clinical medicine · 2026Review
- Cardiac arrest due to tamponade during secondary-stage endovascular stent implantation in a patient with DeBakey type I dissection: a case report and literature review.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transesophageal echocardiography (TEE) has long been established as a cornerstone imaging modality in cardiac surgery and perioperative medicine. In recent years, however, its role has expanded into emergency and intensive care settings, where rapid and accurate hemodynamic assessment is crucial for survival. Point-of-care TEE provides advantages over transthoracic echocardiography when acoustic windows are limited, particularly in mechanically ventilated or critically unstable patients, allowing continuous high-quality visualization of cardiac function, volume status, and great vessel pathology to guide immediate therapeutic interventions. This narrative review examines the evolving role of TEE in acute settings, with emphasis on its application in shock, cardiac arrest, pulmonary embolism, tamponade, and its value in extracorporeal membrane oxygenation (ECMO) cannulation. Advances such as three-dimensional TEE, miniaturized probes, and the integration of artificial intelligence are also discussed, as potential drivers of innovation. While bridging technological progress with clinical practice, TEE emerges as a versatile tool in critical care. However, its broader adoption is still limited by probe availability, operator training, and institutional resources. Overcoming these barriers will be essential to translating technological advances into widespread practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.